Redsense Medical AB Capital Reinvestment Ratio
Redsense Medical AB capital reinvestment ratio. Redsense Medical AB (REDS) has a Capital Reinvestment Ratio of 0.14x as of March 2025, meaning it reinvests 0% of its operating cash flow (Skr761.00K) in capital expenditures (Skr105.00K). Check total reinvestment intensity of Redsense Medical AB to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Redsense Medical AB (2020–2020)
Capital reinvestment ratio of Redsense Medical AB from 2020 to 2020. This chart tracks Redsense Medical AB's Capital Reinvestment Ratio across 1 annual periods. Also explore REDS shareholders equity momentum to track the company's year-over-year net asset growth rate.
Redsense Medical AB Capital Reinvestment Ratio by Year (2020–2020)
Redsense Medical AB capital reinvestment ratio by year from 2020 to 2020. For the full cash flow conversion analysis, see Redsense Medical AB cash conversion from operations.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 2.15x | Skr17.23 Million | Skr37.08 Million | — |